Drug Trial Radar · NCT06215716
A Study Evaluating Efruxifermin in Subjects With Non-Cirrhotic Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis
Last checked: Nov 19, 2026Latest source record: Nov 6, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
1,650
Planned (sponsor's estimate)
Start
Dec 1, 2023
Primary completion
Feb 2033
Study completion Feb 2033
Sponsor
- Lead sponsor
- Akero Therapeutics, IncIndustry
- Sponsor type
- Industry
- First posted
- Jan 22, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multi-center evaluation of efruxifermin (EFX) in a randomized, double-blind, placebo-controlled study in subjects with non-cirrhotic NASH/MASH and fibrosis stage 2 or 3 (F2 or F3). The study will enroll subjects in two cohorts for a total samples size of 1650 subjects.
Conditions
- NASH With Fibrosis
- MASH With Fibrosis
Interventions
EfruxiferminDrug
Administered by subcutaneous injection
PlaceboDrug
Administered by subcutaneous injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Cohort 1 Only: Resolution of NASH/MASH and a ≥ 1 stage improvement in fibrosisTime frame: 52 Weeks
- Event-free survivalTime frame: 240 Weeks
Locations
361 sites in 18 countries. Site status is shown where the registry gives one.
Akero Clinical Study Site
Birmingham, Alabama · Recruiting
Akero Clinical Study Site
Dothan, Alabama · Recruiting
Akero Clinical Study Site
Chandler, Arizona · Recruiting
Akero Clinical Study Site
Flagstaff, Arizona · Completed
Akero Clinical Study Site
Peoria, Arizona · Recruiting
Akero Clinical Study Site
Tucson, Arizona · Recruiting
Akero Clinical Study Site
Tucson, Arizona · Recruiting
Akero Clinical Study Site
Tucson, Arizona · Recruiting
Akero Clinical Study Site
Tucson, Arizona · Recruiting
Akero Clinical Study Site
Conway, Arkansas · Completed
Akero Clinical Study Site
Jonesboro, Arkansas · Completed
Akero Clinical Study Site
Little Rock, Arkansas · Recruiting
Akero Clinical Study Site
North Little Rock, Arkansas · Recruiting
Akero Clinical Study Site
Chula Vista, California · Completed
Akero Clinical Study Site
Coronado, California · Recruiting
Akero Clinical Study Site
Escondido, California · Recruiting
Akero Clinical Study Site
Folsom, California · Recruiting
Akero Clinical Study Site
Inglewood, California · Completed
Akero Clinical Study Site
La Mesa, California · Completed
Akero Clinical Study Site
Lancaster, California · Completed
Akero Clinical Study Site
Lancaster, California · Recruiting
Akero Clinical Study Site
Long Beach, California · Recruiting
Akero Clinical Study Site
Los Angeles, California · Completed
Akero Clinical Study Site
Los Angeles, California · Recruiting
Akero Clinical Study Site
Los Angeles, California · Recruiting
Akero Clinical Study Site
Newport Beach, California · Recruiting
Akero Clinical Study Site
Orange, California · Recruiting
Akero Clinical Study Site
Palm Springs, California · Completed
Akero Clinical Study Site
Pasadena, California · Recruiting
Akero Clinical Study Site
Redwood City, California · Recruiting
Akero Clinical Study Site
Sacramento, California · Recruiting
Akero Clinical Study Site
San Diego, California · Completed
Akero Clinical Study Site
San Diego, California · Completed
Akero Clinical Study Site
San Diego, California · Recruiting
Akero Clinical Study Site
San Francisco, California · Recruiting
Akero Clinical Study Site
San Francisco, California · Recruiting
Akero Clinical Study Site
Santa Maria, California · Recruiting
Akero Clinical Study Site
Aurora, Colorado · Recruiting
Akero Clinical Study Site
Colorado Springs, Colorado · Recruiting
Akero Clinical Study Site
Englewood, Colorado · Recruiting
Showing 40 of 361 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.